Glioblastoma therapy(Polar NanoPharma SL)

N/A

Report date: 2026/01/13 09:34:25

NME

Base Information

Drug NameGlioblastoma therapy(Polar NanoPharma SL)

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPolar NanoPharma SL

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

ATC CodeN/A